CN103212041B - Chinese medicinal composition treating coronary heart disease - Google Patents
Chinese medicinal composition treating coronary heart disease Download PDFInfo
- Publication number
- CN103212041B CN103212041B CN201310093725.5A CN201310093725A CN103212041B CN 103212041 B CN103212041 B CN 103212041B CN 201310093725 A CN201310093725 A CN 201310093725A CN 103212041 B CN103212041 B CN 103212041B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicinal
- radix
- heart disease
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 45
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 26
- 238000011282 treatment Methods 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000009499 grossing Methods 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition treating coronary heart disease. The Chinese medicinal composition is made of the following Chinese medicinal materials by weight: 10-40 parts of bighead atractylodes rhizome, 10-30 parts of Poria, 5-20 parts of Mangnolia officinalis, 3-10 parts of dried ginger, 5-15 parts of Parasitic Loranthus, 3-10 parts of panax notoginseng, 5-25 parts of Ligusticum wallichii, 2-5 parts of asarum, 5-20 parts of fructus psoraleae, 5-20 parts of Radix Ophiopogonis, 5-15 parts of cassia twigs, 10-30 parts of Salvia miltiorrhiza, 5-25 parts of Schisandra chinensis, 5-15 parts of pueraria, 5-20 parts of allium macrostemon, 5-20 parts of rhizoma corydalis, 5-25 parts of radix curcumae, 5-15 parts of rhizoma cyperi, and 5-15 parts of safflower. With the efficacy of soothing liver and dispelling stagnation, tonifying kidney and restoring yang, promoting blood circulation and smoothing veins, invigorating spleen and soothing nerves, the Chinese medicinal composition has obvious coronary heart disease treatment effects and reliable functions. The Chinese medicinal composition disclosed in the invention has the characteristics of wide ingredient medicine sources, simple preparation, mild medicine properties, and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of coronary heart disease.
Background technology
Coronary heart disease is the abbreviation of coronary heart disease, is frequently-occurring disease common clinically, commonly encountered diseases.Modern medicine is thought, coronary heart disease is due to coronary atherosclerosis, or thrombosis is attached on coronary blood tube wall and causes coronary stricture, reduced by coronary artery blood flow, when cardiac load increases suddenly, need blood volume to increase, exceed the compensatory capacity of coronary artery blood supply, or need blood volume not increase, but coronary spasm, decrease blood flow or above-mentioned factor exists simultaneously, all can cause heart sharply, ischemia, anoxia and angina pectoris occurs.At present, the main treatment means one of doctor trained in Western medicine is the formation preventing thrombosis with medicine, and it exists the undesirable deficiency of curative effect instability, course of disease length, recurrent exerbation, effect; Two is carry out coronary artery to expand art, but price costly, and has certain risk, most of patients can not be accepted, and be subject to the restriction of age and armarium again, can not extensively popularize.
The traditional Chinese medical science is thought, coronary heart disease main manifestations is deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and its deficiency in origin can have yang blood and qi virtual loss, real is that the stagnation of QI, cold coagulation, expectorant are turbid, blood stasis, and again can be mutually sick each other, its pathogenesis is blockage of the cardiac vessels, and its sick position with the heart is and relevant with the dirty functional disorder of liver,spleen,kidney three.
According to theory of Chinese medical science, for the pathogeny of coronary heart disease, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Treat that the prevention of coronary heart disease Western medicine exists that curative effect is undesirable, row coronary artery expands art and there is expensive deficiency to overcome in prior art, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of coronary heart disease that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: it is made up of the raw material of Chinese medicine of following weight portion: Rhizoma Atractylodis Macrocephalae 10-40 part, Poria 10-30 part, Cortex Magnoliae Officinalis 5-20 part, Rhizoma Zingiberis 3-10 part, Herba Taxilli 5-15 part, Radix Notoginseng 3-10 part, Rhizoma Chuanxiong 5-25 part, Herba Asari 2-5 part, Fructus Psoraleae 5-20 part, Radix Ophiopogonis 5-20 part, Ramulus Cinnamomi 5-15 part, Radix Salviae Miltiorrhizae 10-30 part, Fructus Schisandrae Chinensis 5-25 part, Radix Puerariae 5-15 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Corydalis 5-20 part, Radix Curcumae 5-25 part, Rhizoma Cyperi 5-15 part, Flos Carthami 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: it is made up of the raw material of Chinese medicine of following weight portion: the Rhizoma Atractylodis Macrocephalae 30 parts, Poria 20 parts, Cortex Magnoliae Officinalis 12 parts, Rhizoma Zingiberis 6 parts, Herba Taxilli 10 parts, Radix Notoginseng 6 parts, Rhizoma Chuanxiong 15 parts, Herba Asari 3 parts, Fructus Psoraleae 15 parts, Radix Ophiopogonis 12 parts, Ramulus Cinnamomi 9 parts, Radix Salviae Miltiorrhizae 20 parts, Fructus Schisandrae Chinensis 15 parts, Radix Puerariae 9 parts, Bulbus Allii Macrostemonis 12 parts, Rhizoma Corydalis 12 parts, Radix Curcumae 15 parts, Rhizoma Cyperi 10 parts, 9 parts, Flos Carthami.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Rhizoma Atractylodis Macrocephalae has the antiabortive effect of invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis; Poria has effect of spleen-benefiting mind-tranquilizing, calm diuresis; Cortex Magnoliae Officinalis has circulation of qi promoting removing food stagnancy, dampness except effect that is full, lowering the adverse QI to relieve asthma; Rhizoma Zingiberis has warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, effect of warming the lung to resolve fluid-retention; Herba Taxilli has effect of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit; Radix Notoginseng has effect of activating blood and removing stasis, hemostasis, reducing swelling and alleviating pain; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Herba Asari has the cold expelling that induces sweat, wind-expelling pain-stopping, warming the lung to resolve fluid-retention, sensible effect; Fructus Psoraleae has effect of reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma; There is Radix Ophiopogonis YIN nourishing and the production of body fluid promoting, effect that lung moistening clears away heart-fire; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Fructus Schisandrae Chinensis has effect of astringent or styptic treatment for spontaneous sweating, the supplementing QI for promoting the production of body fluid of convergence, kidney calming; Radix Puerariae has relieving muscles diaphoresis, invigorating YANG QI to promote eruption, antipyretic effect of promoting the production of body fluid; Bulbus Allii Macrostemonis has effect of activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving, the chest stuffiness relieving of regulating the flow of vital energy; Rhizoma Corydalis has effect of promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving; Radix Curcumae has effect of regulating qi to disperse stagnation, heart fire-clearing upset-relieving; Rhizoma Cyperi has liver-smoothing, qi-regulating
,effect of resolving depression pain relieving; Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, helps using mutually assistant, plays effect of soothing liver-QI for relieving depression, the kidney invigorating recuperating depleted YANG, blood circulation and channel invigorating, spleen-benefiting mind-tranquilizing altogether, reach treating both the principal and the secondary aspects of a disease at the same time to the treatment of coronary heart disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 90.7%, cure rate 46.2%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for coronary heart disease, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 30g, Poria 20g, Cortex Magnoliae Officinalis 12g, Rhizoma Zingiberis 6g, Herba Taxilli 10g, Radix Notoginseng 6g, Rhizoma Chuanxiong 15g, Herba Asari 3g, Fructus Psoraleae 15g, Radix Ophiopogonis 12g, Ramulus Cinnamomi 9g, Radix Salviae Miltiorrhizae 20g, Fructus Schisandrae Chinensis 15g, Radix Puerariae 9g, Bulbus Allii Macrostemonis 12g, Rhizoma Corydalis 12g, Radix Curcumae 15g, Rhizoma Cyperi 10g, Flos Carthami 9g.
Embodiment 2
Treat a Chinese medicine composition for coronary heart disease, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 20g, Poria 30g, Cortex Magnoliae Officinalis 5g, Rhizoma Zingiberis 10g, Herba Taxilli 5g, Radix Notoginseng 10g, Rhizoma Chuanxiong 25g, Herba Asari 2g, Fructus Psoraleae 10g, Radix Ophiopogonis 5g, Ramulus Cinnamomi 10g, Radix Salviae Miltiorrhizae 15g, Fructus Schisandrae Chinensis 5g, Radix Puerariae 10g, Bulbus Allii Macrostemonis 15g, Rhizoma Corydalis 10g, Radix Curcumae 20g, Rhizoma Cyperi 5g, Flos Carthami 10g.
Embodiment 3
Treat a Chinese medicine composition for coronary heart disease, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 40g, Poria 10g, Cortex Magnoliae Officinalis 15g, Rhizoma Zingiberis 5g, Herba Taxilli 8g, Radix Notoginseng 3g, Rhizoma Chuanxiong 10g, Herba Asari 4g, Fructus Psoraleae 12g, Radix Ophiopogonis 20g, Ramulus Cinnamomi 5g, Radix Salviae Miltiorrhizae 25g, Fructus Schisandrae Chinensis 10g, Radix Puerariae 5g, Bulbus Allii Macrostemonis 20g, Rhizoma Corydalis 15g, Radix Curcumae 5g, Rhizoma Cyperi 12g, Flos Carthami 5g.
Embodiment 4
Treat a Chinese medicine composition for coronary heart disease, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 10g, Poria 25g, Cortex Magnoliae Officinalis 20g, Rhizoma Zingiberis 8g, Herba Taxilli 15g, Radix Notoginseng 5g, Rhizoma Chuanxiong 5g, Herba Asari 5g, Fructus Psoraleae 20g, Radix Ophiopogonis 15g, Ramulus Cinnamomi 12g, Radix Salviae Miltiorrhizae 30g, Fructus Schisandrae Chinensis 20g, Radix Puerariae 12g, Bulbus Allii Macrostemonis 5g, Rhizoma Corydalis 20g, Radix Curcumae 10g, Rhizoma Cyperi 15g, Flos Carthami 15g.
Embodiment 5
Treat a Chinese medicine composition for coronary heart disease, it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 25g, Poria 15g, Cortex Magnoliae Officinalis 10g, Rhizoma Zingiberis 3g, Herba Taxilli 12g, Radix Notoginseng 9g, Rhizoma Chuanxiong 20g, Herba Asari 3g, Fructus Psoraleae 5g, Radix Ophiopogonis 10g, Ramulus Cinnamomi 15g, Radix Salviae Miltiorrhizae 10g, Fructus Schisandrae Chinensis 25g, Radix Puerariae 15g, Bulbus Allii Macrostemonis 10g, Rhizoma Corydalis 5g, Radix Curcumae 25g, Rhizoma Cyperi 9g, Flos Carthami 12g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, decocts, and adopts intense fire to decoct at a simmer, with slow fire boiling 20 ~ 30 minutes after boiling; Second decocts, and adds water and does not have powder about 5 centimetres, decoct, and decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
Treat a Chinese medicine composition for coronary heart disease, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 65 example, man 31 example, female 34 example, 30 ~ 70 years old age.
Two, diagnosis basis:
1, feel oppressed pain in Danzhong or pareordia, very then the position such as inside the thorough left shoulder back of the body of pain, throat, left upper arm.In ictal or lasting puzzled.Normal with shortness of breath and palpitation, spontaneous perspiration, very then failing to sleep due to dyspnea;
2, feeling of oppression and pain in the chest is alleviated to dozens of minutes for general several seconds.Severe patient can sharp ache, continues not understand, cold extremities due to sweating, pale complexion, cyanosis of the lips and nails, palpitating speed, or the crisis such as arrhythmia, can die suddenly;
3, be more common in above middle age, often because overworking, depressed angry or polydipsia gluttony, impression is cold and bring out;
4, electrocardiogram, ambulatory electrocardiogram, exercise test etc. are looked into clarify a diagnosis.Make Myocardiase Examination if desired, Dynamic Observation of Electrocardiograms.
Three, usage and dosage: during clinical practice, the component in compositions takes the circumstances into consideration increase and decrease according to the body weight of patient and age.Potion on the one, decocting twice extracting juice is about 300ml, and point morning, evening take for twice.Seven pairs is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) cure: transference cure, electrocardiogram and regarding assay room check recovers normal;
(2) take a turn for the better: symptom alleviates, attack times reduces, and the intermission extends, and lab testing is improved;
(3) do not heal: cardinal symptom and electrocardiogram are without change.
Five, therapeutic effect: in this clinical observation case, takes medicine 3-10 the course for the treatment of, cures 30 examples, follows up a case by regular visits to and have no recurrence; Take a turn for the better 29 examples, and do not heal 6 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1:
Zhang, man, 47 years old.Private prosecution: dizzy more than 3 years uncomfortable in chest, increase the weight of 2 weeks.Examine and see: cardiopalmus, uncomfortable in chest, dizzy, weak, aversion to cold and cold limbs, loose stool, edema of lower limbs, lustreless complexion, words are purple dark, thin white fur of tongue, deep-slow pulse and thin.Examine as coronary heart disease.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, uncomfortable in chest, cardiopalmus alleviates, and stool is shaped; Continue to take 5 courses for the treatment of, all diseases disappear, and cure.
Case 2:
Certain, male late, 51 years old.Because pareordia is uncomfortable, uncomfortable in chest nervous, examination in hospital is examined as coronary heart disease, slightly takes a turn for the better through western medical treatment symptom.First quarter moon cause is busy with one's work, and operating pressure is large, burst precordialgia, and fixing not moving accompanies pain uncomfortable in chest, cardiopalmus, malaise.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain uncomfortable in chest, weak symptom alleviate; Continue and take 2 courses for the treatment of, symptom disappears completely, follows up a case by regular visits to and does not recur half a year again.
Claims (1)
1. treat a Chinese medicine composition for coronary heart disease, it is characterized in that: it is made up of the raw material of Chinese medicine of following weight proportion: Rhizoma Atractylodis Macrocephalae 30g, Poria 20g, Cortex Magnoliae Officinalis 12g, Rhizoma Zingiberis 6g, Herba Taxilli 10g, Radix Notoginseng 6g, Rhizoma Chuanxiong 15g, Herba Asari 3g, Fructus Psoraleae 15g, Radix Ophiopogonis 12g, Ramulus Cinnamomi 9g, Radix Salviae Miltiorrhizae 20g, Fructus Schisandrae Chinensis 15g, Radix Puerariae 9g, Bulbus Allii Macrostemonis 12g, Rhizoma Corydalis 12g, Radix Curcumae 15g, Rhizoma Cyperi 10g, Flos Carthami 9g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310093725.5A CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310093725.5A CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103212041A CN103212041A (en) | 2013-07-24 |
| CN103212041B true CN103212041B (en) | 2015-03-11 |
Family
ID=48810427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310093725.5A Expired - Fee Related CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103212041B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977244B (en) * | 2014-06-06 | 2016-09-28 | 吴军 | A kind of Chinese medicine treating coronary heart disease |
| CN105749158A (en) * | 2016-03-16 | 2016-07-13 | 曲思廉 | Traditional Chinese medicine for treating coronary heart disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1209121C (en) * | 2001-04-29 | 2005-07-06 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
| CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN101057946B (en) * | 2007-05-09 | 2010-04-14 | 王云花 | Traditional Chinese medicine for treating heart disease |
| CN101181600B (en) * | 2007-11-20 | 2010-07-21 | 王振才 | Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| CN101468148B (en) * | 2007-12-27 | 2011-11-16 | 郭太平 | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same |
| CN101249250A (en) * | 2008-03-24 | 2008-08-27 | 李运乃 | Medicinal liquor preparation for treating thoracic obstruction and chest pain caused by cold phlegm, qi stagnation, blood stasis and collateral obstruction |
-
2013
- 2013-03-22 CN CN201310093725.5A patent/CN103212041B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103212041A (en) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316204B (en) | One treats hypertensive Chinese medicine composition | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN103007192B (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103251754A (en) | Traditional Chinese medicine composition for treating bedsore | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
| CN105079768A (en) | Traditional Chinese medicine composition for treating coronary heart disease caused by syndrome of phlegm obstruction | |
| CN103550689B (en) | A kind of Chinese medicine composition for the treatment of the thoracic obstruction | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN104645002A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: DONG WEI Free format text: FORMER OWNER: SUN SHENGBO Effective date: 20150210 |
|
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dong Wei Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: DONG WEI SUN SHENGBO |
|
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150210 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 (Rongcheng City Hospital) Applicant after: Dong Wei Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Sun Shengbo |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 Termination date: 20160322 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |